Monthly Archives: November 2016

The last decade has seen a surge in investigation of stem cell populations in the gastrointestinal tract, establishing LGR5 as the gold standard marker of active stem cells in the bases of intestinal crypts.1 Other stem cell markers, including HOPX, BM… Continue reading →

The last decade has seen a surge in investigation of stem cell populations in the gastrointestinal tract, establishing LGR5 as the gold standard marker of active stem cells in the bases of intestinal crypts.1 Other stem cell markers, including HOPX, BM… Continue reading →

Hepatitis C virus (HCV) remains a major global health burden, with approximately 150 million people persistently infected. Chronically infected individuals are at increased risk for severe progressive liver disease, including cirrhosis and hepatocellul… Continue reading →

Hepatitis C virus (HCV) remains a major global health burden, with approximately 150 million people persistently infected. Chronically infected individuals are at increased risk for severe progressive liver disease, including cirrhosis and hepatocellul… Continue reading →

Familial adenomatous polyposis (FAP) and the Lynch syndrome are the most common and well-known high-penetrance genetic syndromes that confer inherited risks of colorectal cancer (CRC). In each case, the culpable genes were identified by linkage studies… Continue reading →

Familial adenomatous polyposis (FAP) and the Lynch syndrome are the most common and well-known high-penetrance genetic syndromes that confer inherited risks of colorectal cancer (CRC). In each case, the culpable genes were identified by linkage studies… Continue reading →

The incidence and mortality of hepatocellular carcinoma (HCC) have been reported to be plateauing in the United States. The United States has large racial, ethnic, and regional variation; we collected data from all 50 states to better analyze changes i… Continue reading →

The incidence and mortality of hepatocellular carcinoma (HCC) have been reported to be plateauing in the United States (US). The US has large racial, ethnic, and regional variation; we collected data from all 50 states to better analyze changes in inci… Continue reading →

Inflammatory bowel diseases (IBD) are emerging in newly industrialized countries in Asia, South America, and the Middle East and, therefore, IBD has evolved into a global disease. With such an increasing prevalence in every continent, the costs of heal… Continue reading →

Inflammatory bowel diseases (IBD) are emerging in newly industrialized countries in Asia, South America, and the Middle East and, therefore, IBD has evolved into a global disease. With such an increasing prevalence in every continent, the costs of heal… Continue reading →